Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-02-01

Clinical Trial Update: Ulinastatin in Inhalation Lung Injury [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 clinical trial evaluating ulinastatin for inhalation injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ulinastatin (ulinastatin)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Inhalation Injury | Phase 2 | Status: UNKNOWN